Introduction
Pseudogout is caused by the deposition of calcium pyrophosphate crystals in and around the joints, where they provoke inflammation. The condition develops when the normal chemistry of cartilage and joint fluid is disrupted enough for these crystals to form, accumulate, and trigger an immune response. In most cases, the process is linked to aging and to conditions that alter mineral metabolism, but inherited factors, metabolic disorders, trauma, and certain illnesses can also contribute. Understanding pseudogout means understanding how crystal formation begins, why it localizes to joints, and what internal or external factors increase that risk.
Biological Mechanisms Behind the Condition
The key event in pseudogout is the formation of calcium pyrophosphate dihydrate, or CPP, crystals. These crystals usually develop in articular cartilage, the smooth tissue that covers the ends of bones within a joint. Cartilage is not merely structural material; it is a biologically active tissue that regulates the turnover of inorganic pyrophosphate, a molecule involved in mineral balance. Under normal conditions, the body keeps pyrophosphate and calcium levels in a controlled range so crystals do not readily form.
Pseudogout occurs when that balance shifts. Cartilage cells, known as chondrocytes, can produce excess pyrophosphate, or the mechanisms that break it down may become less effective. When pyrophosphate concentration becomes too high in the joint environment, it binds with calcium and forms CPP crystals. These crystals may remain embedded in cartilage or shed into the synovial fluid that lubricates the joint. Once released, they are recognized by the immune system as irritants. White blood cells respond, inflammatory molecules are released, and the joint becomes swollen, painful, and stiff.
The inflammatory reaction is important because the crystals themselves are not the entire problem. Their presence initiates a chain reaction. Crystal phagocytosis by neutrophils and macrophages activates inflammatory signaling pathways, including cytokines and chemotactic factors that amplify the response. That is why a deposit of microscopic crystals can produce a sudden, intense arthritis. The process is similar in concept to gout, but the crystal type is different: pseudogout involves calcium pyrophosphate rather than uric acid.
Primary Causes of Pseudogout
Aging is the strongest overall factor associated with pseudogout. As joints age, cartilage undergoes biochemical and structural change. The balance of enzymes, transport proteins, and cellular signals that regulate pyrophosphate metabolism becomes less stable. Older cartilage is also more vulnerable to microscopic damage, which can expose or alter the matrix in ways that encourage crystal nucleation. For this reason, pseudogout becomes much more common later in life, even without a single identifiable trigger.
Joint cartilage degeneration is another major cause. Wear and tear, osteoarthritis, or prior mechanical damage can change the cartilage matrix where crystals form. Damaged cartilage may release matrix fragments that act as a scaffold for crystallization. In addition, chondrocytes in degenerating cartilage can behave abnormally, producing more pyrophosphate than usual. This makes the joint environment more favorable for CPP crystal formation and retention.
Inherited abnormalities in mineral metabolism can also lead to pseudogout. Some people are born with genetic changes that affect how pyrophosphate is transported or regulated in cartilage. These inherited differences are less common than age-related disease, but they can produce earlier onset and more widespread crystal deposition. When the biochemical systems that control extracellular pyrophosphate are disrupted from the start, crystals may form more easily and persist longer.
Metabolic disorders are a major group of causes because they alter the chemical environment of the joint. Disorders such as hyperparathyroidism, hemochromatosis, hypomagnesemia, and hypophosphatasia are all associated with CPP crystal formation. Each affects mineral handling in a different way, but the shared result is a disturbance in the calcium-phosphate-pyrophosphate balance that supports crystal growth.
Hyperparathyroidism raises calcium levels and can alter bone and cartilage mineral metabolism, increasing the chance that calcium will combine with pyrophosphate in joint tissues. Hemochromatosis, an iron overload disorder, may damage cartilage and interfere with enzymes that regulate crystal formation. Hypomagnesemia removes a protective influence, since magnesium normally helps inhibit crystal growth and stabilizes mineral balance. Hypophosphatasia reduces alkaline phosphatase activity, which impairs breakdown of pyrophosphate and allows it to accumulate.
Joint trauma or surgery can precipitate pseudogout by injuring cartilage and synovial tissue. A damaged joint may release matrix components and create local inflammation, both of which encourage crystal shedding and deposition. People sometimes develop attacks after an injury, an operation, or even a sudden mechanical stress to a previously vulnerable joint. In these cases, the trauma does not create crystals from nothing, but it can convert silent crystal deposits into an acute inflammatory episode.
Contributing Risk Factors
Genetic influences can shape susceptibility even when a person does not have a clearly inherited crystal disorder. Variations in genes involved in cartilage metabolism, mineral transport, and inflammatory signaling may influence whether CPP crystals form and how strongly the immune system reacts to them. Family history can therefore matter, especially in people who develop pseudogout at a relatively young age or in multiple joints.
Environmental and mechanical exposures may also contribute indirectly. Repeated joint stress, long-term occupational strain, and prior injuries can accelerate cartilage degeneration. This is important because the cartilage matrix is the main site where crystals originate. The more often cartilage is disrupted, the more likely its biochemical environment will favor crystal nucleation.
Infections are not usually the root cause of pseudogout, but they can act as triggers or confounders. Systemic illness may alter hydration, metabolic balance, and inflammatory tone. In some settings, an infection can precipitate a flare in a joint already loaded with CPP crystals by intensifying immune activation. The crystals are still the cause of the pseudogout process, but infection can be the event that reveals it.
Hormonal changes influence mineral regulation and therefore can contribute to risk. Hormones such as parathyroid hormone affect calcium balance, bone turnover, and phosphate handling. When endocrine control is altered, the joint environment may become more favorable to CPP crystal development. This is one reason why endocrine disorders are frequently included among the underlying causes of pseudogout.
Lifestyle factors are generally less direct than in some other diseases, but they can still matter through their effects on joint health and metabolism. Poor nutritional status may contribute to electrolyte disturbances such as low magnesium, while obesity can increase mechanical stress on weight-bearing joints and worsen osteoarthritis. These influences do not create CPP crystals on their own, but they can lower the threshold for crystal deposition and inflammation.
How Multiple Factors May Interact
Pseudogout rarely has a single cause operating in isolation. More often, several biological influences overlap. For example, an older adult with osteoarthritis may already have cartilage degeneration that promotes crystal formation. If that person also has low magnesium or mild hyperparathyroidism, the biochemical environment becomes even more favorable for CPP crystal accumulation. A minor injury to the joint may then be enough to trigger an acute inflammatory attack.
These interactions matter because crystal formation and inflammation are linked systems. Cartilage damage increases the chance of crystal deposition, and crystals in turn provoke inflammatory injury that can further damage cartilage. Over time, this can create a self-reinforcing cycle. The joint becomes both a site of crystal production and a target of inflammation, which helps explain why recurrent episodes can occur in the same joint.
Variations in Causes Between Individuals
The causes of pseudogout differ from person to person because susceptibility depends on the interplay of genetics, age, joint history, and systemic health. In one individual, the primary driver may be inherited abnormalities in pyrophosphate regulation. In another, it may be age-related cartilage degeneration with no clear metabolic disorder. Another person may develop pseudogout because of endocrine disease or after joint surgery.
Age is especially important because it alters both cartilage biology and the body’s ability to maintain mineral balance. Younger people who develop pseudogout are more likely to have an identifiable underlying disorder, while older adults may develop it from cumulative tissue wear and biochemical drift. Health status also matters: kidney disease, endocrine disease, and nutritional deficits can change calcium, magnesium, or phosphate handling and therefore modify crystal risk. Environmental exposure, prior trauma, and the specific joints involved also help determine why one person develops the condition and another does not.
Conditions or Disorders That Can Lead to Pseudogout
Several medical conditions are classically associated with pseudogout because they alter mineral metabolism or damage cartilage. Hyperparathyroidism can increase calcium availability and disrupt phosphate balance, encouraging calcium pyrophosphate crystal formation. Hemochromatosis can damage joint structures and is strongly linked to CPP crystal deposition, particularly in characteristic patterns of arthritis. Hypomagnesemia removes an important inhibitor of crystal growth, making the joint environment more permissive for deposition.
Hypophosphatasia is especially relevant because alkaline phosphatase normally helps break down pyrophosphate. When this enzyme is deficient, pyrophosphate accumulates and the risk of CPP crystallization rises. Osteoarthritis is also closely connected. Although osteoarthritis and pseudogout are different conditions, degenerative cartilage provides a substrate in which crystals can form, and CPP crystal deposition can worsen joint degeneration. In practice, these disorders often overlap rather than appearing as completely separate processes.
Other conditions, including chronic kidney disease, severe systemic illness, and post-traumatic joint changes, may also increase susceptibility by altering mineral homeostasis or stressing the cartilage matrix. The common thread is not one disease mechanism, but a shift in the local joint environment toward conditions that favor crystal formation and inflammatory activation.
Conclusion
Pseudogout develops when calcium pyrophosphate crystals form in joint cartilage and trigger inflammation after entering the synovial space. The condition reflects a breakdown in the normal regulation of pyrophosphate, calcium, and cartilage metabolism. Aging is the most common background factor, but metabolic disorders, endocrine abnormalities, joint damage, and inherited influences can all contribute. In many people, several of these factors act together, gradually creating a joint environment that supports crystal deposition.
Understanding the causes of pseudogout is mainly a matter of understanding the biology of crystal formation. Once cartilage chemistry shifts, even small crystals can provoke a strong immune response and produce the acute inflammatory arthritis characteristic of the condition. The specific cause varies from person to person, but the underlying process is the same: altered mineral regulation leads to CPP crystal deposition, and those crystals drive the disease.